Is 603041 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 603041 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 603041 (CN¥10.91) is trading above our estimate of fair value (CN¥3.69)
Significantly Below Fair Value: 603041 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 603041?
Key metric: As 603041 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for 603041. This is calculated by dividing 603041's market cap by their current
earnings.
What is 603041's PE Ratio?
PE Ratio
18.3x
Earnings
CN¥107.74m
Market Cap
CN¥1.98b
603041 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: 603041 is good value based on its Price-To-Earnings Ratio (18.3x) compared to the CN Chemicals industry average (35.2x).
Price to Earnings Ratio vs Fair Ratio
What is 603041's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
603041 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
18.3x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 603041's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.